There’s been a high-stakes global tax fight over tech for a decade, with billions of dollars at stake for leading U.S.

The transcription factor CREM is a pivotal regulator of NK cell function, making CREM a valuable target to increase the efficacy of anticancer immunotherapies based on this cell population and ...